{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:17:59Z","timestamp":1788250679200,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaad.2019.09.028","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:01:12Z","timestamp":1569438072000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review"],"prefix":"10.1016","volume":"82","author":[{"given":"Jodie","family":"Raffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raagini","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.09.028_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.09.028_bib2","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2019.09.028_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.12358","article-title":"The multiple factors affecting the association between atopic dermatitis and contact sensitization","volume":"69","author":"Thyssen","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2019.09.028_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","article-title":"Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis","volume":"131","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.09.028_bib5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/jid.2013.148","article-title":"Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis","volume":"133","author":"Newell","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaci.2014.11.017","article-title":"Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin","volume":"135","author":"Correa da Rosa","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.09.028_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archderm.1989.01670150056006","article-title":"A longitudinal study of contact sensitivity in patients with atopic dermatitis","volume":"125","author":"Uehara","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archderm.1973.01620170029009","article-title":"Allergic contact sensitivity in atopic dermatitis","volume":"107","author":"Jones","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1398-9995.2012.02863.x","article-title":"The association between contact sensitization and atopic disease by linkage of a clinical database and a nationwide patient registry","volume":"67","author":"Thyssen","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2019.09.028_bib10","first-page":"186","article-title":"A pragmatic approach to patch testing atopic dermatitis patients: clinical recommendations based on expert consensus opinion","volume":"27","author":"Chen","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2019.09.028_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2019.09.028_bib12","first-page":"287","article-title":"Terminology of contact dermatitis","volume":"50","author":"Wilkinson","year":"1970","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.09.028_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jdcr.2018.08.027","article-title":"The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy","volume":"4","author":"Suresh","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2019.09.028_bib14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2019.09.028_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamadermatol.2018.4098","article-title":"Patch testing and allergen-specific inhibition in a patient taking dupilumab","volume":"155","author":"Raffi","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0105-1873.2004.00351.x","article-title":"Reproducibility of patch test results: a concurrent right-versus-left study using TRUE Test","volume":"50","author":"Ale","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib17","first-page":"193","article-title":"Reproducibility of patch tests: a United States multicenter study","volume":"3","author":"Belsito","year":"1992","journal-title":"Am J Contact Dermat"},{"key":"10.1016\/j.jaad.2019.09.028_bib18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0190-9622(89)70329-7","article-title":"Reproducibility of patch tests","volume":"21","author":"Gollhausen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cod.12836","article-title":"Variation in aluminium patch test reactivity over time","volume":"77","author":"Siemund","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1046-199X(99)90001-5","article-title":"Individual variation in nickel patch test reactivity","volume":"10","author":"Hinds\u00e9n","year":"1999","journal-title":"Am J Contact Dermat"},{"key":"10.1016\/j.jaad.2019.09.028_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1982.tb00389.x","article-title":"The persistence of allergic contact sensitivity: a 10-year follow-up in 100 patients","volume":"107","author":"Keczkes","year":"1982","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0536.1988.tb02811.x","article-title":"Epidemiology of nickel allergy: results of a follow-up analysis of patients with positive patch tests to nickel","volume":"18","author":"Schubert","year":"1988","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0536.1979.tb04857.x","article-title":"Evaluation and relevance of isolated test reactions to cobalt","volume":"5","author":"Rystedt","year":"1979","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0536.1995.tb02072.x","article-title":"The development and course of test reactions to gold sodium thiosulfate","volume":"33","author":"Bruze","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cod.12053","article-title":"Unexpected loss of contact allergy to aluminium induced by vaccine","volume":"68","author":"Gente Lidholm","year":"2013","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0264-410X(03)00531-0","article-title":"Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer","volume":"22","author":"Bergfors","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2019.09.028_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/DER.0000000000000357","article-title":"Patch testing in a patient on dupilumab","volume":"29","author":"Hoot","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/DER.0000000000000346","article-title":"Positive patch test reaction in a patient taking dupilumab","volume":"29","author":"Puza","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2019.03.020","article-title":"Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis","volume":"51","author":"Stout","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2018.12.048","article-title":"A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis","volume":"80","author":"Chipalkatti","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cod.13266","article-title":"Blocking type 2 inflammation by dupilumab does not control classic (Type 1-driven) allergic contact dermatitis in chronic hand eczema","volume":"81","author":"Crepy","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DER.0000000000000414","article-title":"Dupilumab as a treatment for allergic contact dermatitis","volume":"29","author":"Chipalkatti","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib33","doi-asserted-by":"crossref","first-page":"e12701","DOI":"10.1111\/dth.12701","article-title":"A case series of dupilumab-treated allergic contact dermatitis patients","volume":"31","author":"Goldminz","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2019.09.028_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/DER.0000000000000409","article-title":"Effective use of dupilumab in managing systemic allergic contact dermatitis","volume":"29","author":"Joshi","year":"2018","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaad.2019.09.028_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2018.07.043","article-title":"Dupilumab use in allergic contact dermatitis","volume":"80","author":"Machler","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.028_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219327720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219327720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:45Z","timestamp":1759272825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219327720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0190962219327720"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.028","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}